Table 2.
Rates of pretreatment comorbidity for treatment completers and noncompleters
| Pretreatment variable | Completers (n = 256) | Noncompleters (n = 123) |
|---|---|---|
| Number (%) of patients | Number (%) of patients | |
| Any comorbidity | 117 (45.7%) | 68 (55.3%) |
| Any Anxiety | 99 (38.7%) | 60 (48.9%) |
| Any depression | 48 (18.8%) | 24 (19.5%) |
| GAD | 65 (25.4%) | 39 (31.7%) |
| MDD | 42 (16.4%) | 20 (16.3%) |
| Specific phobia | 30 (11.7%) | 22 (17.9%) |
| Social phobia | 28 (10.9%) | 20 (16.3%) |
| OCD | 15 (5.9%) | 5 (4.1%) |
| PTSD | 10 (3.9%) | 11 (8.9%) |
| Hypochondriasis | 9 (3.5%) | 6 (4.9%) |
| Dysthymia | 8 (3.1%) | 5 (4.1%) |
| 1 comorbid diagnosis | 58 (22.7%) | 25 (20.3%) |
| 2 comorbid diagnoses | 38 (14.8%) | 31 (25.2%) |
| 3 comorbid diagnoses | 14 (5.5%) | 8 (6.5%) |
| 4 or more comorbid diagnoses | 7 (2.7%) | 4 (3.3%) |
GAD generalized anxiety disorder; MDD major depressive disorder; OCD obsessive–compulsive disorder; PTSD posttraumatic stress disorder.